Access brought to you by: LOCKSS
Login
Omarigliptin vs Sitagliptin Phase 3 Study Design
AHA, antihyperglycemic agent; MTT, mixed-meal tolerance test; R, randomization; T2DM, type 2 diabetes mellitus.
MTT at visit 10 performed 1 d after sitagliptin or 7 d after omarigliptin.
Reproduced with permission from I Gantz, MD.
Change in HbA1c (%) Through Week 24
LS, least squares; SE standard error.
Change in 2-Hour Postmeal Glucose at Week 24
LS, least squares; PMG, postmeal glucose; SE standard error.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.